2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer

Sander Dumont,Vincent Vandecaveye,Toon Van Gorp,Thaïs Baert,Els Van Nieuwenhuysen,Patrick Neven,Sileny Han,Raphaëla Carmen Dresen,Patrick Berteloot,Frédéric Amant

doi:10.1136/ijgc-2022-esgo.583

2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer

Sander Dumont, Vincent Vandecaveye + Show 8 more

Open Access

https://doi.org/10.1136/ijgc-2022-esgo.583

Copy DOI

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society	Publication Date: Oct 1, 2022
Citations: 1

Affiliation: KU Leuven

#Whole-body Diffusion-weighted MRI #Resectable Disease + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Introduction/BackgroundCurrent ESGO guidelines recommend secondary cytoreductive surgery (SCS) followed by chemotherapy in case of first recurrent epithelial ovarian cancer and a platinum-free interval (TFIp) of >6 months as it is...

Full Text